2.53Open2.02Pre Close52 Volume14 Open Interest46.00Strike Price13.16KTurnover94.18%IV2.75%PremiumDec 20, 2024Expiry Date1.23Intrinsic Value100Multiplier4DDays to Expiry1.30Extrinsic Value100Contract SizeAmericanOptions Type0.6274Delta0.0825Gamma18.89Leverage Ratio-0.2420Theta0.0029Rho11.85Eff Leverage0.0184Vega
Viking Therapeutics Stock Discussion
loading...
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
No comment yet